arrow
返回
Q

Qingzhou Kong

Qilu Hospital of Shandong University

11H指数
41论文数
365被引数
收录论文 16
发表时间
Vonoprazan-Based Dual and Quadruple Therapy with Varying Duration for Helicobacter pylori Eradication: A Multicenter, Randomized Controlled TrialVonoprazan为基础的双联和四联疗法治疗幽门螺杆菌根除:一项多中心、随机对照试验
err2026-08-01
err0
PREAI
errKunping Ju; Hanyue Zhao; Leina Guo; Zhenzhen Zhai; Xiaohui Song; Hongyu Zhao; Weiwei Zhang; Xiaowei Li; Huijuan Zhang; Wei Xia; Ruiqi Zheng; Shangshang Liu; Longfei Sun; Ruihao Ding; Xuyan Liu; Teng Teng; Qingzhou Kong; Yueyue Li; Xiuli Zuo; Yanqing Li
err分享
err收藏
Untitled Reply无标题回复
err2026-02-01
err0
PREAI
errZhao, Hanyue; Kong, Qingzhou; Li, Yueyue
err分享
err收藏
AI-Based D-Amino Acid Substitution for Optimizing Antimicrobial Peptides to Treat Multidrug-Resistant Bacterial Infection基于AI的D-氨基酸取代优化抗菌肽治疗多重耐药细菌感染
err2026-01-14
err0
errOAAI
errYinuo Zhao; Qingzhou Kong; Haifan Gong; Lixiang Li; Jialu Fu; Boyao Wan; Peizhu Wang; Xiaojuan Li; Yue Wang; Jinghui Zhang; Yanbo Yu; Xiaoyun Yang; Xiuli Zuo; Haina Wang; Yanqing Li
err分享
err收藏
Methodological considerations for recurrence analysis
errENDOSCOPY
IF12.8
err2025-11-01
err0
PREAI
errWang, Baobao; Kong, Qingzhou; Li, Yueyue; Li, Yanqing
err分享
err收藏
Seven-Day Versus 14-Day Tegoprazan and Tetracycline-Containing Quadruple Therapy for First-Line Eradication of Helicobacter pylori Infection: A Randomized, Open-Label, Noninferiority Trial七日与十四日Tegoprazan联合四环素四联疗法用于幽门螺杆菌感染一线根除的随机、开放标签、非劣效性试验
err2025-04-24
err0
PREAI
errNan, Xue-Ping; Zhao, Hong-Yu; Guo, Lei-Na; Zheng, Rui-Qi; Wang, Xi-Lan; Wang, Yong-Fen; Su, Yan-Hua; Geng, Wen-Rong; Liu, Xiu-Lan; Xu, Hai-Miao; Zhou, Ke-Lun; Guo, Yu-Ting; Cao, Jian-Hua; Han, Zhong-Xue; Kong, Qing-Zhou; Zuo, Xiu-Li; Li, Yan-Qing; Li, Yue-Yue
err分享
err收藏
Efficacy and Safety of Cefuroxime-Tetracycline-Containing Bismuth Quadruple Therapy for Helicobacter pylori Eradication in Penicillin-Allergic Patients: A Multicenter Randomized Controlled Trial西罗莫司-四环素含铋四联疗法在青霉素过敏患者中根除幽门螺杆菌的疗效与安全性:一项多中心随机对照试验
err2025-04-16
err1
PREAI
errWang, Hui; Kong, Qingzhou; Zhang, Qiumei; Zhang, Lili; Li, Ruili; Zhang, Teng; Guo, Leina; Wang, Xilan; Li, Xiaowei; Zhao, Hongyu; Liu, Fengqing; Guo, Yuting; Zhai, Zhenzhen; Li, Mingyu; Yang, Xiaorong; Zuo, Xiuli; Yang, Xiaoyun; Li, Yueyue
err分享
err收藏
err分享
err收藏
err分享
err收藏
Health information in short videos about metabolic dysfunction-associated steatotic liver disease: Analysing quality and reliability
err2024-03-05
err5
PREAI
errDing, Ruihao; Kong, Qingzhou; Sun, Longfei; Liu, Xuyan; Xu, Leiqi; Li, Yueyue; Zuo, Xiuli; Li, Yanqing
err分享
err收藏
Efficacy and safety of a 14-day modified concomitant therapy for refractory Helicobacter pylori infection: a pilot study
err2023-09-13
err1
PREAI
errZeng, Shu-yan; Wang, Juan; Liu, Jing; Lin, Min-Juan; Lin, Bo-Shen; Ding, Yu-Ming; Kong, Qing-Zhou; Zhang, Wen-Lin; Duan, Miao; Han, Zhong-Xue; Li, Yue-yue; Zuo, Xiu-Li; Li, Yan-Qing
err分享
err收藏
The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day: a systematic review and meta-analysis
err2022-12-20
err14
PREAI
errDing, Yu-Ming; Li, Yue-Yue; Liu, Jing; Wang, Juan; Wan, Meng; Lin, Min-Juan; Lin, Bo-Shen; Zhang, Wen-Lin; Kong, Qing-Zhou; Wang, Shao-Tong; Mu, Yi-Jun; Duan, Miao; Han, Zhong-Xue; Zuo, Xiu-Li; Li, Yan-Qing
err分享
err收藏